Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.12 USD | +1.90% | -6.46% | +48.53% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.53% | 345M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.38% | 21.6B | |
-12.38% | 22.31B | |
-6.54% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Solid Biosciences New Drug Application for Duchenne Muscular Dystrophy Gets FDA Clearance; Shares Soar Premarket